Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-15

FDA Approved: CLINIMIX E — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for Clinimix E, Baxter's intravenous parenteral nutrition product, approving its updated formulation components.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLINIMIX E

Snippet

SUPPL AP for CLINIMIX E (LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE)